Contact us
Pneumococcus portfolio
Streptococcus pneumoniae (Pneumococcus) is a leading cause of invasive disease worldwide. The World Health Organization (WHO) estimates that pneumococcal infections cause around 1.6 million deaths annually. It is considered the most common cause of community-acquired pneumonia and can lead to meningitis, bacteremia, and other severe complications1.
As Pneumococcus is a primary target of global vaccination programs, accurate serotyping and ongoing surveillance are essential for vaccine research and public health. Rapid diagnosis remains critical to guide effective treatment.
The WHO, in its surveillance standard Vaccine-Preventable Diseases Surveillance Standards: Pneumococcus, states serotyping as the gold standard: “Capsular typing remains essential for pneumococcal surveillance and epidemiology. Molecular methods may be used as complementary tools in certain contexts, but they do not replace serotyping as the primary approach2. This surveillance data is critical for evaluating vaccine performance and guiding immunization strategies.
Pneumococcus strains
Pneumococcal strains: Reference strains for more than 90 serotypes.
Pneumococcus antisera
Pool, group, factor and type antisera for Neufeld (Quellung) and latex agglutination tests, covering more than 90 serotypes.
Pneumococcus antigens
Pneumococcal antigens including CWPS and serotype specific capsular polysaccharides.
ImmuView® S. pneumoniae and
L. pneumophila
A rapid urinary Antigen test able to identify both S. pneumoniae and Legionnaires’ disease at the same time – with just one test
ImmuView® S. pneumonia
A rapid urinary antigen test for detecting presumed pneumococcal pneumonia or meningitis.
Get in touch
If you have any questions, comments, or collaboration inquiries, you are very welcome to reach out.
Please fill in the form and we will get back to you as soon as possible.